Patents by Inventor Michael Hallek

Michael Hallek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Papilloma virus capsomere vaccine formulations and method of use
    Publication number: 20030021806
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: November 7, 2001
    Publication date: January 30, 2003
    Inventors: Michael Hallek, Alexander Burger
  • Papilloma virus capsomere vaccine formulations and methods of use
    Publication number: 20020197668
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: April 3, 2001
    Publication date: December 26, 2002
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Recombinant AAV vector-based transduction system and use of same
    Publication number: 20020192826
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Application
    Filed: August 12, 2002
    Publication date: December 19, 2002
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • Adeno-associated virus vector for boosting immunogenicity of cells
    Publication number: 20020168385
    Abstract: The present invention provides an Adeno-Associated Virus (AAV) vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Application
    Filed: July 2, 2002
    Publication date: November 14, 2002
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells
    Patent number: 6448074
    Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: October 9, 2000
    Date of Patent: September 10, 2002
    Assignee: MediGene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6440742
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: August 27, 2002
    Assignee: Medigene, AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • System for the production of AAV vectors
    Publication number: 20020081709
    Abstract: The invention concern a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans.
    Type: Application
    Filed: July 18, 2001
    Publication date: June 27, 2002
    Applicant: MEDIGENE AG.
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Papilloma virus capsomere vaccine formulations and methods of use
    Publication number: 20020039584
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Application
    Filed: March 30, 2001
    Publication date: April 4, 2002
    Applicant: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • Recombinant AAV vector-based transduction system and use of same
    Publication number: 20020028514
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. Furthermore, this invention concerns the use of the transduction system.
    Type: Application
    Filed: January 31, 2001
    Publication date: March 7, 2002
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • Papillomavirus truncated L1 protein and fusion protein constructs
    Patent number: 6352696
    Abstract: Vaccine formulations comprising viral capsomeres are disclosed along with methods for their production. Therapeutic and prophylactic methods of use for the vaccine formulations are also disclosed.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: March 5, 2002
    Assignee: Medigene AG
    Inventors: Michael Hallek, Alexander Burger
  • System for the production of AAV vectors
    Patent number: 6294370
    Abstract: The invention concerns a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans. The invention also concerns the use of such a system for the production of AAV vectors.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: September 25, 2001
    Assignee: Medigene AG
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6207453
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: March 27, 2001
    Assignee: Medigene AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • Adeno-associated virus vector for boosting immunogenicity of freshly isolated tumor cells
    Patent number: 6171597
    Abstract: The present invention provides an AAV vector having a foreign DNA coding for a protein that boosts immunogenicity of cells. The invention also provides a vaccine containing such a vector and the use of both.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: January 9, 2001
    Assignee: Medigene AG
    Inventors: Gerhard Maass, Michael Hallek, Christoph Bogedain